Scientists at Kessler Foundation are presenting findings of recent cognitive research studies in multiple sclerosis at the Hilton San Diego Bayfront in San Diego, CA, May 30-June2, 2012. Drs. John DeLuca, Nancy Chiaravalloti and Yael Goverover are addressing the Fourth Cooperative Meeting of the Consortium of Multiple Sclerosis Centers (CMSC) and the Americas Committee for Treatment and Research (ACTRIMS).
This 26th Annual Meeting of the CMSC and 17th Annual Meeting of ACTRIMS are the signature, educational events for each organization.
Cognitive impairment is one of the most common symptoms of multiple sclerosis (MS), experienced by up to two-thirds of patients. Cognitive impairments have been described by patients as one of the most debilitating symptoms of the disease, significantly affecting everyday life functional activities such as vocational, family, and social functioning. Despite this knowledge, relatively little research has been conducted in cognitive functioning in persons with MS.
John DeLuca, PhD, VP of Research & Training chairs Workshop 6: Cognitive Rehabilitation in MS. Dr. DeLuca discusses assessment of cognitive problems and introduces common evidence-based techniques for improving cognitive functioning in persons with MS. Nancy Chiaravalloti, PhD, director of Neuropsychology & Neuroscience Research, presents two recent double-blind, placebo-controlled, randomized control trials of behavioral interventions designed to specifically improve learning and memory in persons with MS. Yael Goverover, PhD, OT, focuses on techniques to improve learning and memory, with a specific emphasis on improving everyday functional activity. Dr. Goverover, visiting scientist from New York University, is a former fellow at Kessler Foundation.
Research links COVID-19 vaccines to temporary facial palsy in over 5,000 patients